Fsd Pharma Inc

General ticker "HUGE" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $132.1M

Fsd Pharma Inc does not follow the US Stock Market performance with the rate: -41.5%.

Estimated limits based on current volatility of 13.0%: low 3.28$, high 4.25$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [20.69$, 68.05$]
  • 2023-12-31 to 2024-12-30 estimated range: [7.78$, 32.20$]

Financial Metrics affecting the HUGE estimates:

  • Negative: Operating Income to Revenue ratio of -1.00 <= 0.01
  • Negative: Non-GAAP EPS of -0.70 <= 0.11
  • Negative: Operating Cash Flow per share of -0.73 <= 0.22
  • Negative: negative Net Income
  • Negative: Industry Operating Cash Flow per share (median) of -0.73 <= 0.31
  • Negative: Industry Operating Income to Revenue ratio (median) of -0.78 <= 0.02

Similar symbols

Short-term HUGE quotes

Long-term HUGE plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $30.69MM $33.74MM $27.43MM
Operating Income $-30.69MM $-33.74MM $-27.43MM
Non-Operating Income $2.24MM $-0.19MM $0.73MM
Interest Expense $0.24MM $0.07MM $0.05MM
R&D Expense $7.83MM $6.33MM $6.91MM
Income(Loss) $-28.45MM $-33.94MM $-26.70MM
Taxes $4.27MM $1.47MM $-3.38MM
Profit(Loss) $-32.72MM $-35.41MM $-23.32MM
Stockholders Equity $36.31MM $54.13MM $30.54MM
Assets $41.97MM $62.96MM $38.41MM
Operating Cash Flow $-19.13MM $-20.75MM $-28.33MM
Investing Cash Flow $6.51MM $0.27MM $12.12MM
Financing Cash Flow $24.17MM $38.21MM $-2.07MM
Earnings Per Share* $-2.72 $-1.01 $-0.60

* EPS are Split Adjusted, recent splits may be reflected with a delay.